Enzo Life Sciences SuperFasLigand for enhanced immune activation

Friday, 17 October, 2014 | Supplied by: United Bioresearch Products Pty Ltd


The critical role of signals transmitted via TNF ligands and receptors in mediating inflammation, cancer and immunity are well established. Recombinant TNF ligands can be used in drug development to enhance immune activation. Oligomerisation of TNF ligands using enhancers and expression of self-oligomerising chimeric proteins have been shown to improve stability and significantly enhance immune activation compared to that achieved with recombinant ligands alone.

SuperFasLigand is soluble, human and recombinant. It is said to provide enhanced immune activation compared to other recombinant ligands. The product features an N-terminus linker shown to improve stability and mimics glycosylation of native human FasL.

Online: www.unitedbioresearch.com.au
Phone: 02 4575 0309
Related Products

Cytek cFluor Human B Cell Monitoring Kit

The Cytek cFluor Human B Cell Monitoring Kit identifies B cell subsets in human peripheral blood...

Primerdesign exsig Mag RapidBead Pro Extraction Kit

Primerdesign's exsig Mag RapidBead Pro Extraction Kit is a next-generation, magnetic...

Cayman Chemical Cellular Metabolism Screening Library

Cayman Chemical's Cellular Metabolism Screening Library consists of two plates and contains...


  • All content Copyright © 2025 Westwick-Farrow Pty Ltd